US eyes permanent change to digital health regulatory pathDevelopers of digital health tools have benefited from a truncated route to market during the COVID-19 crisis, and Share XUS eyes permanent change to digital health regulatory pathhttps://pharmaphorum.com/news/us-eyes-permanent-change-to-digital-health-regulatory-path/
Novartis and Pear to develop substance use digital therapeuticsNovartis is set to develop and commercialise a range of digital therapeutics for patients with substance and opioid Share XNovartis and Pear to develop substance use digital therapeuticshttps://pharmaphorum.com/news/novartis-digital-therapeutics-sandoz-pear/
Big names from pharma, Google, Dreamworks join cognitive therapy company AkiliAll will work on the development of Akili’s gaming therapy portfolio. Share XBig names from pharma, Google, Dreamworks join cognitive therapy company Akilihttps://pharmaphorum.com/news/cubist-google-dreamworks-akili/